Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Molecular Oncology|January 14, 2017
Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cellsChun-Yu Liu, Jung-Chen Su, Tzu-Ting Huang, et al.
The Journal of Infectious Diseases|February 11, 2025
Sex differences in anti-EBV antibody responsesSarah S Jackson, Julia Francis, Ruth M Pfeiffer, et al.
Hepatology (Baltimore, Md.)|March 21, 2025
Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort studyTzu-I Chen, Ming-Huang Chen, Szu-Ching Yin, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 17, 2020
Epidemiology of Virus Infection and Human CancerChien-Jen Chen, San-Lin You, Wan-Lun Hsu, et al.
Experimental & Molecular Medicine|August 12, 2017
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.
International Journal of Cancer|June 9, 2004
Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in TaiwanAmy Pickard, Chien-Jen Chen, Scott R Diehl, et al.
Ebiomedicine|April 9, 2020
Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progressionTzu-Ting Huang, Ling-Ming Tseng, Ji-Lin Chen, et al.
The Journal of Infectious Diseases|March 7, 2018
Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus ProteomeZhiwei Liu, Anna E Coghill, Ruth M Pfeiffer, et al.
Experimental Cell Research|May 20, 2023
Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer modelLing-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, et al.
Pageof 16